Virus filtration are mainly used to maintain a pathogen such as bacteria, virus, and microbe’s free environment. Presence of pathogens in labs, and biotechnology industries lead to the contamination of water, air, and biotheraputics. Virus filtration maintains the environment and products safety. It also ensures that the products manufactured are of high grade. The market research study on “Virus Filtration Market (By Product Type: Virus Filters & Filtration Systems, Kits & Reagents, Services; By Application: Biological [Blood & Blood Products, Tissue & Tissue Products, Vaccines & Therapeutics, Cellular & Gene Therapy Products, Stem Cell Products], Medical Devices, Water Purification, Air Purification; By End-user: Pharmaceutical and Biotechnology Companies, Contract Research Organization, Medical Devices Companies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers a detailed outlook, strategic recommendations, and insightful viewpoints on the global virus filtration market. The report also analyzes the key players operating in virus filtration market and identifies the key strategies deployed by them along with the market share of leading players. The global virus filtration market is segmented as below:
Virus Filtration Market by Product Type
Virus Filtration Market by Application
Virus Filtration Market by End-user
Virus Filtration Market by Geography
The global virus filtration market is expected to grow at a CAGR of approximately 12.2% in terms of value by 2026. Rise in occurrence of chronic diseases such as diabetes, cancer, and autoimmune disorders is the major driving factor for global virus filtration market. Moreover, the rise in therapeutics infection caused by viruses also boosts the growth of virus filtration market globally. In addition, the upsurge in research & development expenses coupled with government initiative also boosts the market worldwide. However, the rigorous rules & regulations regarding the filtration of products is likely to restrict the growth of virus filtration during the forecast period. Also, the consolidated filtration market hampers the market growth. Nevertheless, rise in the awareness regarding chronic diseases in emerging economies offers huge growth opportunities for virus filtration manufacturers during the forecast period.
Virus filtration market has been segmented based on product type, application, and end-user.Based on product type the market has been segmented as virus filters &filtration systems, kits and reagents, and services. On the basis of application, the market has been divided as biological, medical devices, water purification and air purification. Biological segment has been further sub-segmented as blood & blood products, tissue & tissue products, vaccines & therapeutics, cellular & gene therapy products, and stem cell products. Based on end-user, the global virus filtration market has been split into pharmaceutical & biotechnology companies, medical devices companies, research institutes and contract research organizations.
North America was the largest revenue generator for global virus filtration market in 2013 owing to the presence of key manufacturers in the region. In addition, the augmented demand for filtration products also supported the growth of virus filtration market in the region. Asia-Pacific is projected to be the most attractive market for the manufacturers of virus filtration throughout the forecast period due to the increase in population and rise in the number of chronic diseases infected population. The market will also be supported by the favorable government initiatives and cheap labor cost.
Some of the leading companies operating in the global virus filtration market include Merck KGaA, General Electric, Lonza, Danaher, WuXiPharmaTech (Cayman) Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation, Sartorius AG, and Asahi Kasei Medical Co., Ltd.